Suppr超能文献

术前阿片类药物使用与术后再入院

Preoperative Opioid Use and Readmissions Following Surgery.

机构信息

University of Michigan Medical School, Ann Arbor, MI.

Section of Plastic Surgery, Department of Surgery, Michigan Medicine, Ann Arbor, MI.

出版信息

Ann Surg. 2022 Jan 1;275(1):e99-e106. doi: 10.1097/SLA.0000000000003827.

Abstract

OBJECTIVE

To assess the association between preoperative opioid exposure and readmissions following common surgery.

SUMMARY BACKGROUND DATA

Preoperative opioid use is common, but its effect on opioid-related, pain-related, respiratory-related, and all-cause readmissions following surgery is unknown.

METHODS

We analyzed claims data from a 20% national Medicare sample of patients ages ≥ 65 with Medicare Part D claims undergoing surgery between January 1, 2009 and November 30, 2016. We grouped patients by the dose, duration, recency, and continuity of preoperative opioid prescription fills. We used logistic regression to examine the association between prior opioid exposure and 30-day readmissions, adjusted for patient risk factors and procedure type.

RESULTS

Of 373,991 patients, 168,579 (45%) filled a preoperative opioid prescription within 12 months of surgery, ranging from minimal to chronic high use. Preoperative opioid exposure was associated with higher rate of opioid-related readmissions, compared with naive patients [low: aOR=1.63, 95% CI=1.26-2.12; high: aOR=3.70, 95% CI=2.71-5.04]. Preoperative opioid exposure was also associated with higher risk of pain-related readmissions [low: aOR=1.27, 95% CI=1.23-1.32; high: aOR=1.62, 95% CI=1.53-1.71] and respiratory-related readmissions [low: aOR=1.10, 95% CI=1.05-1.16; high: aOR=1.44, 95% CI=1.34-1.55]. Low, moderate, and high chronic preoperative opioid exposures were predictive of all-cause readmissions (low: OR 1.09, 95% CI: 1.06-1.12); high: OR 1.23, 95% CI: 1.18-1.29).

CONCLUSIONS

Higher levels of preoperative opioid exposure are associated with increased risk of readmissions after surgery. These findings emphasize the importance of screening patients for preoperative opioid exposure and creating risk mitigation strategies for patients.

摘要

目的

评估术前阿片类药物暴露与常见手术后再入院之间的关系。

背景资料概要

术前使用阿片类药物很常见,但它对手术后与阿片类药物相关的、与疼痛相关的、与呼吸相关的以及所有原因的再入院的影响尚不清楚。

方法

我们分析了来自 Medicare 全国 20%样本中年龄≥65 岁的患者的索赔数据,这些患者在 2009 年 1 月 1 日至 2016 年 11 月 30 日期间进行了 Medicare 部分 D 理赔手术。我们根据术前阿片类药物处方的剂量、持续时间、最近使用情况和连续性将患者分组。我们使用逻辑回归来检查术前阿片类药物暴露与 30 天再入院之间的关系,调整了患者的风险因素和手术类型。

结果

在 373991 名患者中,168579 名(45%)在手术前 12 个月内开了术前阿片类药物处方,从最低到慢性高剂量使用不等。与无阿片类药物暴露的患者相比,术前阿片类药物暴露与更高的阿片类药物相关再入院率相关[低剂量:aOR=1.63,95%CI=1.26-2.12;高剂量:aOR=3.70,95%CI=2.71-5.04]。术前阿片类药物暴露也与更高的疼痛相关再入院风险相关[低剂量:aOR=1.27,95%CI=1.23-1.32;高剂量:aOR=1.62,95%CI=1.53-1.71]和呼吸相关再入院[低剂量:aOR=1.10,95%CI=1.05-1.16;高剂量:aOR=1.44,95%CI=1.34-1.55]。低、中、高慢性术前阿片类药物暴露预测所有原因的再入院率(低:OR 1.09,95%CI:1.06-1.12);高:OR 1.23,95%CI:1.18-1.29)。

结论

较高水平的术前阿片类药物暴露与手术后再入院风险增加有关。这些发现强调了对患者进行术前阿片类药物暴露筛查和为患者制定风险缓解策略的重要性。

相似文献

1
Preoperative Opioid Use and Readmissions Following Surgery.术前阿片类药物使用与术后再入院
Ann Surg. 2022 Jan 1;275(1):e99-e106. doi: 10.1097/SLA.0000000000003827.
3

引用本文的文献

6
Perioperative Opioid-Related Harms: Opportunities to Minimize Risk.围手术期阿片类药物相关危害:降低风险的机会
Semin Plast Surg. 2024 Feb 18;38(1):61-68. doi: 10.1055/s-0043-1778043. eCollection 2024 Feb.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验